Sharda Cropchem quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	1,052	929	+13.2%
EBITDA	164	133	+23.5%
EBITDA margin	15.6%	14.3%	+1.3 pts
Profit before tax	107	85.7	+25.4%
Net profit	91.7	74.4	+23.4%
EPS	₹10.17	₹8.24	+23.4%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	1,052	1,074	2,065	1,289	929	985	1,829	929	777	785	1,312	632	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	44.6	34.5	22.4	21.2	29.4	32.5	25.2	0.6	25.5	19.3	−2.0	12.2
	1,096	1,108	2,087	1,310	958	1,017	1,854	930	802	804	1,310	645
	268	374	915	548	376	391	828	318	295	336	603	279
	450	476	73.1	434	424	315	304	573	300	135	209	266
	−44.2	−170	307	−143	−192	−70.3	152	−265	−32.1	85.7	46.3	−78.6
	17.9	17.7	23.0	16.5	12.3	14.9	18.2	12.3	10.4	11.2	14.7	9.4
	0.9	1.8	0.5	0.4	0.3	0.6	0.4	0.5	0.5	0.8	0.2	0.9
	100	100	87.0	83.3	76.2	78.1	71.9	68.9	69.1	64.8	54.3	68.6
	196	190	260	193	176	119	223	177	115	141	184	86.8
	989	990	1,665	1,131	873	848	1,598	884	757	774	1,112	633
	164	186	487	241	133	215	303	115	89.6	77.0	255	69.5
	63.8	85.7	400	158	56.7	137	231	45.8	20.5	12.3	201	0.9
Profit
	107	118	422	179	85.7	169	256	45.9	45.5	30.8	198	12.1
	107	118	422	179	85.7	169	256	45.9	45.5	30.8	198	12.1
	7.5	31.7	67.8	22.5	10.5	33.3	30.5	14.6	2.6	5.6	29.7	1.7
	8.2	−1.3	35.5	11.0	0.8	−7.0	22.0	0.2	0.5	−2.1	25.2	5.8
	15.8	30.4	103	33.4	11.4	26.3	52.5	14.8	3.1	3.5	54.9	7.5
	91.7	88.0	319	145	74.4	143	204	31.1	42.4	27.3	143	4.6
	91.7	88.0	319	145	74.4	143	204	31.1	42.4	27.3	143	4.6
	−4.8	19.8	42.0	9.4	6.9	5.0	9.2	−8.8	7.6	6.4	−3.5	3.8
	86.9	108	361	155	81.3	148	213	22.3	50.0	33.7	140	8.4
	91.8	88.0	319	145	74.3	143	204	31.1	42.4	27.3	143	4.6
	−0.1	−0.0	0.1	−0.0	0.0	0.0	0.0	−0.0	0.0	−0.0	0.0	0.0
Per share
	₹10.17	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51
	₹10.17	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51
Other comprehensive income — detail
	−4.8	19.8	42.0	9.4	6.9	5.0	9.2	—	—	—	—	—
	0.2	−0.0	−0.1	0.1	−0.1	0.0	0.2	−0.0	−0.0	−0.0	−0.2	0.0
	0.0	−0.0	−0.0	0.0	−0.0	0.0	0.0	—	—	—	—	—
	—	—	—	—	—	—	—	−0.0	−0.0	−0.0	−0.0	0.0
	−4.9	19.8	42.0	9.3	7.0	5.0	9.0	−8.8	7.6	6.5	−3.4	3.8
	87.0	108	361	155	81.2	148	213	22.3	50.0	33.7	140	8.4
	−0.1	−0.0	0.1	−0.0	0.0	0.0	0.0	−0.0	0.0	−0.0	0.0	0.0
Per share — as-filed variants
	₹10.17	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51
	₹10.17	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	378	394	770	450	321	349	544	304	215	229	454	166
	35.9%	36.7%	37.3%	34.9%	34.5%	35.5%	29.8%	32.7%	27.6%	29.2%	34.6%	26.2%
Adjusted (ex-exceptional items) — derived
	107	118	422	179	85.7	169	256	45.9	45.5	30.8	198	12.1
	91.7	88.0	319	145	74.4	143	204	31.1	42.4	27.3	143	4.6
	₹10.17	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHARDACROP₹642.00

Sharda Cropchem Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersUPL PIIND STYRENIX REFEX SUDARSCHEM SUDEEPPHRM RCF RALLISMcap ₹5,792 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	632.5	1,312.1	785.1	776.9	929.3	1,828.5	984.8	929.1	1,288.8	2,064.9	1,073.8	1,051.7
Other Income	12.2	-2.0	19.3	25.5	0.6	25.2	32.5	29.4	21.2	22.4	34.5	44.6
Total Income	644.6	1,310.0	804.4	802.4	929.9	1,853.8	1,017.3	958.5	1,310.0	2,087.3	1,108.3	1,096.3
Expenses
+ Cost of Materials Consumed	279.2	603.0	335.7	294.6	317.9	828.2	390.6	376.2	547.6	914.5	373.5	268.3
+ Purchases of Stock-in-Trade	266.2	208.9	134.9	299.7	572.6	304.1	315.3	423.9	433.7	73.1	476.4	449.7
+ Changes in Inventories	-78.6	46.3	85.7	-32.1	-265.4	152.2	-70.3	-191.7	-142.8	307.1	-170.2	-44.2
+ Employee Benefit Expense	9.4	14.7	11.2	10.4	12.3	18.2	14.9	12.3	16.5	23.0	17.7	17.9
+ Finance Costs	0.9	0.2	0.8	0.5	0.5	0.4	0.6	0.3	0.4	0.5	1.8	0.9
+ Depreciation & Amortisation	68.6	54.3	64.8	69.1	68.9	71.9	78.1	76.2	83.3	87.0	100.3	100.4
+ Other Expenses	86.8	184.3	140.7	114.7	177.3	222.6	119.0	175.5	192.8	260.1	190.4	196.0
Total Expenses	632.5	1,111.6	773.6	756.9	884.0	1,597.7	848.2	872.8	1,131.4	1,665.3	989.9	988.8
EBITDA	69.5	254.8	77.0	89.6	114.7	303.2	215.3	132.9	241.0	487.1	186.0	164.1
EBIT	0.9	200.6	12.3	20.5	45.8	231.3	137.2	56.7	157.7	400.1	85.7	63.8
Profit
PBT before Exceptional Items	12.1	198.4	30.8	45.5	45.9	256.1	169.1	85.7	178.6	422.1	118.4	107.5
Pretax Income	12.1	198.4	30.8	45.5	45.9	256.1	169.1	85.7	178.6	422.1	118.4	107.5
+ Current Tax	1.7	29.7	5.6	2.6	14.6	30.5	33.3	10.5	22.5	67.8	31.7	7.5
+ Deferred Tax	5.8	25.2	-2.1	0.5	0.2	22.0	-7.0	0.8	11.0	35.5	-1.3	8.2
Tax Expense	7.5	54.9	3.5	3.1	14.8	52.5	26.3	11.4	33.4	103.4	30.4	15.8
Net Income	4.6	143.5	27.3	42.4	31.1	203.6	142.8	74.4	145.1	318.7	88.0	91.7
+ Net Income — Continuing Ops	4.6	143.5	27.3	42.4	31.1	203.6	142.8	74.4	145.1	318.7	88.0	91.7
+ Other Comprehensive Income	3.8	-3.5	6.4	7.6	-8.8	9.2	5.0	6.9	9.4	42.0	19.8	-4.8
Total Comprehensive Income	8.4	140.0	33.7	50.0	22.3	212.8	147.8	81.3	154.5	360.7	107.8	86.9
Net Income to Common	4.6	143.5	27.3	42.4	31.1	203.6	142.8	74.3	145.1	318.6	88.0	91.8
Minority Interest	0.0	0.0	-0.0	0.0	-0.0	0.0	0.0	0.0	-0.0	0.1	-0.0	-0.1
Per Share
Basic EPS	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76	10.17
Diluted EPS	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76	10.17
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	9.2	5.0	6.9	9.4	42.0	19.8	-4.8
+ Items NOT to be Reclassified to P&L	0.0	-0.2	-0.0	-0.0	-0.0	0.2	0.0	-0.1	0.1	-0.1	-0.0	0.2
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	0.0	0.0	-0.0	0.0	-0.0	-0.0	0.0
+ Tax on Items NOT to be Reclassified — alt tag	0.0	-0.0	-0.0	-0.0	-0.0	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	3.8	-3.4	6.5	7.6	-8.8	9.0	5.0	7.0	9.3	42.0	19.8	-4.9
Comprehensive Income — Owners of Parent	8.4	140.0	33.7	50.0	22.3	212.7	147.8	81.2	154.5	360.6	107.8	87.0
Comprehensive Income — Non-controlling Interests	0.0	0.0	-0.0	0.0	-0.0	0.0	0.0	0.0	-0.0	0.1	-0.0	-0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76	10.17
Diluted EPS — Continuing Operations	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76	10.17
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	165.6	453.8	228.9	214.7	304.2	544.0	349.2	320.7	450.3	770.2	394.0	377.9
Gross Margin %	26.18	34.59	29.15	27.63	32.73	29.75	35.46	34.52	34.94	37.30	36.69	35.94
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	12.1	198.4	30.8	45.5	45.9	256.1	169.1	85.7	178.6	422.1	118.4	107.5
Net Income Adj (tax-effected)	4.6	143.5	27.3	42.4	31.1	203.6	142.8	74.4	145.1	318.7	88.0	91.7
EPS Adj	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76	10.17
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sharda Cropchem Q2 FY27 results (July–September 2026)

Filed with NSE on Friday, 30 October 2026 at 1:30 pm IST

Sharda Cropchem (NSE: SHARDACROP) reported its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026 at 1:30 pm IST. Consolidated net profit was ₹91.8 crore, up 23.5% from ₹74.3 crore in Q2 FY26 and up 4.3% from ₹88 crore in Q1 FY27. Revenue from operations was ₹1,052 crore, up 13.2% year on year and down 2.1% from the previous quarter.

Q2 FY26 results (a year earlier): 30 October 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹91.8 Cr+23.5% vs Q2 FY26+4.3% vs Q1 FY27
Revenue from operations: ₹1,052 Cr+13.2% vs Q2 FY26−2.1% vs Q1 FY27
Operating margin (EBIT): 6.1%unchanged vs Q2 FY26−1.9 pts vs Q1 FY27EBIT ₹63.8 Cr
EBITDA: ₹164 Cr+23.5% vs Q2 FY26−11.8% vs Q1 FY27margin 15.6%
Earnings per share (basic): ₹10.17+23.4% vs Q2 FY26+4.2% vs Q1 FY27
Net profit margin: 8.7%+0.7 pts vs Q2 FY26+0.5 pts vs Q1 FY27

Questions

What was Sharda Cropchem's net profit in Q2 FY27?

Consolidated net profit was ₹91.8 crore, up 23.5% from ₹74.3 crore in Q2 FY26 and up 4.3% from ₹88 crore in Q1 FY27.

What is Sharda Cropchem's net profit margin?

Sharda Cropchem's net profit margin was 8.7% in Q2 FY27 (net profit as a share of revenue from operations), against 8.0% in Q2 FY26 (up 0.7 percentage points). For FY26 as a whole it was 12.9%.

What was Sharda Cropchem's net profit in FY26?

Consolidated net profit was ₹681 crore in FY26 (April 2025–March 2026), up 123.7% from ₹304 crore in FY25. It was ₹31.9 crore in FY24 and ₹342 crore in FY23: up 99.1% over three years, 25.8% a year on average.

What was Sharda Cropchem's revenue in Q2 FY27?

Revenue from operations was ₹1,052 crore, up 13.2% year on year and down 2.1% from the previous quarter.

What was Sharda Cropchem's EPS in Q2 FY27?

Basic earnings per share were ₹10.17, against ₹8.24 in Q2 FY26.

What was Sharda Cropchem's revenue in FY26?

Revenue from operations was ₹5,268 crore in FY26 (April 2025–March 2026), up 21.9% from ₹4,320 crore in FY25. It was ₹3,163 crore in FY24 and ₹4,045 crore in FY23: up 30.2% over three years, 9.2% a year on average.

How were Sharda Cropchem's Q2 FY27 results?

Both grew from a year earlier: net profit was up 23.5% at ₹91.8 crore and revenue was up 13.2% at ₹1,052 crore. The operating margin was 6.1%, unchanged from 6.1% a year earlier. Against Q1 FY27, net profit was up 4.3% and revenue down 2.1%.

What was Sharda Cropchem's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹63.8 crore, a margin of 6.1%, against 8.0% in Q1 FY27 and 6.1% in Q2 FY26. EBITDA was ₹164 crore, 15.6% of revenue.

What was Sharda Cropchem's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹180 crore, down 17.2% from ₹217 crore in the same months a year earlier. Revenue from operations was ₹2,125 crore, up 11.1%.

How has Sharda Cropchem's profit changed over the last four quarters?

Net profit by quarter: ₹145 crore in Q3 FY26, ₹319 crore in Q4 FY26, ₹88 crore in Q1 FY27 and ₹91.8 crore in Q2 FY27. That is ₹644 crore over the four quarters, up 42.4% from ₹452 crore in the four quarters before. Revenue from operations: ₹1,289 crore, ₹2,065 crore, ₹1,074 crore and ₹1,052 crore.

When did Sharda Cropchem announce its Q2 FY27 results?

On Friday, 30 October 2026 at 1:30 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 30 October 2025.

When will Sharda Cropchem announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Sharda Cropchem figures come from?

From Sharda Cropchem's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 30 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.